Randy Schweickart is currently a Director of Engineering in the Cell Therapy Technology and Platforms Department at Juno Therapeutics, a wholly owned subsidiary of Celgene Corp. In this role he is responsible for the development and implementation of equipment and automation for CAR-T and TCR therapy manufacturing processes. These activities are focused on both the transformation of current generation process equipment as well as advancement of next generation manufacturing plant concepts and process technologies.
Randy has over 25 years of equipment and automation design experience in the biopharmaceutical industry with prior positions at ICOS/CMC and Amgen. He has been a key contributor in the pioneering of high productivity, manufacturing-scale, perfusion-based biomanufacturing processes and implementation of reconfigurable manufacturing plant concepts utilizing single-use systems and portable process equipment.
Prior experiences include designing equipment for Space Shuttle flight experiments and serving as a Principle Investigator in a microbiology microgravity experiment that flew on the final Columbia mission. Randy has a B.S. degree in Civil Engineering from MIT and an M.S. degree in Mechanical Engineering from the Center for Biochemical Engineering at Duke University.